• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定抽动秽语综合征的潜在药物靶点:一项基于可成药基因的孟德尔随机化研究。

Identifying potential drug targets for tourette syndrome: a Mendelian randomization study based on druggable genes.

作者信息

Zhou Shilin, Li Lixin

机构信息

College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.

The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, China.

出版信息

Ital J Pediatr. 2025 Jun 9;51(1):185. doi: 10.1186/s13052-025-02048-x.

DOI:10.1186/s13052-025-02048-x
PMID:40490792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12150520/
Abstract

BACKGROUND

Tourette syndrome (TS) is a chronic neurodevelopmental disorder with childhood onset characterized by multiple motor tics and at least one vocal tic, with symptoms persisting for over one year. Its exact etiology remains unclear. Identifying novel therapeutic targets for TS is critically important.

METHODS

We utilized cis-expression quantitative trait loci (cis-eQTLs) of druggable genes obtained from the eQTLGen Consortium and genome-wide association study (GWAS) data for TS from the Psychiatric Genomics Consortium as the outcome to simulate the effects of pharmacological interventions on TS via Mendelian randomization (MR). Colocalization analyses were then conducted to validate the findings. To further corroborate these results, we investigated the role of DNA methylation in mediating the relationship between druggable gene expression and TS.

RESULTS

The expression of seven druggable genes was significantly associated with TS susceptibility (FDR < 0.05). TS susceptibility and three key genes (RET, CAPNS1, and LAMA5) were likely to share a causal variant. Further DNA methylation analysis identified seven critical methylation sites (cg02605258, cg02907768, cg06026331, cg09831553, cg12382846, cg19674797, and cg20752878), which indirectly influence TS development by regulating LAMA5 gene expression.

CONCLUSION

LAMA5 is the most promising potential drug target for mitigating TS risk. Our study not only reveals potential therapeutic targets but also provides directions for future TS drug development.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1186/s13052-025-02048-x.

摘要

背景

抽动秽语综合征(TS)是一种儿童期起病的慢性神经发育障碍,其特征为多种运动性抽动和至少一种发声性抽动,症状持续超过一年。其确切病因尚不清楚。确定TS的新治疗靶点至关重要。

方法

我们利用从eQTLGen联盟获得的可成药基因的顺式表达定量性状位点(cis-eQTLs)以及精神基因组学联盟提供的TS全基因组关联研究(GWAS)数据作为结果,通过孟德尔随机化(MR)模拟药物干预对TS的影响。然后进行共定位分析以验证结果。为了进一步证实这些结果,我们研究了DNA甲基化在介导可成药基因表达与TS之间关系中的作用。

结果

七个可成药基因的表达与TS易感性显著相关(FDR < 0.05)。TS易感性与三个关键基因(RET、CAPNS1和LAMA5)可能共享一个因果变异。进一步的DNA甲基化分析确定了七个关键甲基化位点(cg02605258、cg02907768、cg06026331、cg09831553、cg12382846、cg19674797和cg20752878),它们通过调节LAMA5基因表达间接影响TS的发展。

结论

LAMA5是降低TS风险最有前景的潜在药物靶点。我们的研究不仅揭示了潜在的治疗靶点,还为未来TS药物开发提供了方向。

补充信息

在线版本包含可在10.1186/s13052-025-02048-x获取的补充材料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d7/12150520/c6535512619c/13052_2025_2048_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d7/12150520/c6535512619c/13052_2025_2048_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31d7/12150520/c6535512619c/13052_2025_2048_Fig1_HTML.jpg

相似文献

1
Identifying potential drug targets for tourette syndrome: a Mendelian randomization study based on druggable genes.确定抽动秽语综合征的潜在药物靶点:一项基于可成药基因的孟德尔随机化研究。
Ital J Pediatr. 2025 Jun 9;51(1):185. doi: 10.1186/s13052-025-02048-x.
2
Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.基于汇总数据的孟德尔随机化确定了多发性硬化症的潜在可药物治疗靶点的优先级。
Brain Commun. 2020 Aug 14;2(2):fcaa119. doi: 10.1093/braincomms/fcaa119. eCollection 2020.
3
Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.孟德尔随机化分析确定了可用于慢性阻塞性肺疾病的可成药基因和药物再利用。
Front Cell Infect Microbiol. 2024 Apr 10;14:1386506. doi: 10.3389/fcimb.2024.1386506. eCollection 2024.
4
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.基于可成药基因的孟德尔随机化研究:鉴定特发性肺纤维化的潜在药物靶点
Respir Res. 2024 May 23;25(1):217. doi: 10.1186/s12931-024-02848-5.
5
Identifying potential drug targets for seborrheic keratosis through druggable genome-wide Mendelian randomization and colocalization analysis.通过可药物化全基因组孟德尔随机化和共定位分析确定脂溢性角化病的潜在药物靶点。
Arch Dermatol Res. 2025 Feb 7;317(1):359. doi: 10.1007/s00403-025-03875-y.
6
Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.基于系统药物基因组全基因组孟德尔随机化鉴定糖尿病治疗靶点。
Front Endocrinol (Lausanne). 2024 Jun 10;15:1366290. doi: 10.3389/fendo.2024.1366290. eCollection 2024.
7
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum.全基因组范围内可靶向药物的系统性孟德尔随机化研究确定了妊娠剧吐的治疗靶点。
BMC Pregnancy Childbirth. 2024 Dec 23;24(1):848. doi: 10.1186/s12884-024-07077-8.
8
Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.鉴定乳腺癌的可操作药物靶点:孟德尔随机化和基于人群的分析。
EBioMedicine. 2023 Dec;98:104859. doi: 10.1016/j.ebiom.2023.104859. Epub 2023 Oct 28.
9
Identification of Therapeutic Targets for Hyperuricemia: Systematic Genome-Wide Mendelian Randomization and Colocalization Analysis.高尿酸血症治疗靶点的鉴定:全基因组孟德尔随机化与共定位系统分析
Biomedicines. 2025 Apr 23;13(5):1022. doi: 10.3390/biomedicines13051022.
10
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes.探索出血性中风可药物治疗基因的系统性孟德尔随机化研究
Mol Neurobiol. 2025 Feb;62(2):1359-1372. doi: 10.1007/s12035-024-04336-9. Epub 2024 Jul 9.

本文引用的文献

1
Unraveling the Controversy: The Causal Link Between Osteoarthritis and Alzheimer's Disease.揭开争议:骨关节炎与阿尔茨海默病之间的因果联系
Brain Behav. 2025 Mar;15(3):e70455. doi: 10.1002/brb3.70455.
2
Unpacking Tourette Syndrome in Children: Insights into Prevalence and Comorbidities from NSCH Data.剖析儿童抽动秽语综合征:基于全国儿童健康调查(NSCH)数据对患病率及共病情况的见解
J Clin Med. 2025 Feb 23;14(5):1485. doi: 10.3390/jcm14051485.
3
Candidate Genetic Modifiers in Alport Syndrome: A Case Series.奥尔波特综合征的候选基因修饰因子:病例系列
Life (Basel). 2025 Feb 14;15(2):298. doi: 10.3390/life15020298.
4
Multiomic QTL mapping reveals phenotypic complexity of GWAS loci and prioritizes putative causal variants.多组学QTL定位揭示了全基因组关联研究(GWAS)位点的表型复杂性,并对潜在的因果变异进行了优先级排序。
Cell Genom. 2025 Mar 12;5(3):100775. doi: 10.1016/j.xgen.2025.100775. Epub 2025 Feb 21.
5
Brief description of Mendelian randomized studies.孟德尔随机化研究简介。
Rev Esp Enferm Dig. 2025 Aug;117(8):484-485. doi: 10.17235/reed.2024.10917/2024.
6
Population-wide DNA methylation polymorphisms at single-nucleotide resolution in 207 cotton accessions reveal epigenomic contributions to complex traits.207份棉花种质资源在单核苷酸分辨率下的全群体DNA甲基化多态性揭示了表观基因组对复杂性状的贡献。
Cell Res. 2024 Dec;34(12):859-872. doi: 10.1038/s41422-024-01027-x. Epub 2024 Oct 17.
7
Impact of negative emotions on upper gastrointestinal diseases: A Mendel randomization study.负性情绪对胃肠道上部疾病的影响:一项孟德尔随机化研究。
PLoS One. 2024 Jul 12;19(7):e0304121. doi: 10.1371/journal.pone.0304121. eCollection 2024.
8
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.基于可成药基因的孟德尔随机化研究:鉴定特发性肺纤维化的潜在药物靶点
Respir Res. 2024 May 23;25(1):217. doi: 10.1186/s12931-024-02848-5.
9
Uncovering a causal connection between the genus in fecal microbiota and non-alcoholic fatty liver disease: a two-sample Mendelian randomization analysis.揭示粪便微生物群中的属与非酒精性脂肪性肝病之间的因果关系:一项两样本孟德尔随机化分析。
Front Microbiol. 2023 Dec 12;14:1276790. doi: 10.3389/fmicb.2023.1276790. eCollection 2023.
10
Congenital nephrotic syndrome with diffuse mesangial sclerosis caused by compound heterozygous mutation in LAMA5 gene.由 LAMA5 基因复合杂合突变引起的弥漫性系膜硬化性先天性肾病综合征。
Pediatr Nephrol. 2024 May;39(5):1421-1425. doi: 10.1007/s00467-023-06223-2. Epub 2023 Nov 20.